Open access · OA
via Europe PMC
Effect of the JAK Inhibitor Baricitinib on Cytokine Production and Bone Properties in a Mouse Model of Accelerated Aging.
Gelles K, Kurz V, Butylina M, Wahl-Figlash K, Schepelmann M, Meshcheryakova A, Pietschmann P.
International journal of molecular sciences · 2026
Abstract
Age-related osteoporosis is characterized by progressive loss of bone mass and deterioration of bone microarchitecture, leading to enhanced skeletal fragility. Cytokines regulate bone remodeling through distinct signaling pathways. Baricitinib, a selective JAK1/2 inhibitor effective in inflammatory disorders such as rheumatoid arthritis, suppresses cytokine signaling, but its role in age-related osteoporosis remains insufficiently defined. In our study a total of 60 eight-month-old female SAMP8 mice were randomized to receive baricitinib (10 mg/kg) or vehicle twice daily by oral gavage for six weeks. Bone outcomes were evaluated by high-resolution micro-computed tomography (µCT) and static histomorphometry. Intracellular cytokine production by splenocytes was determined via flow cytometry. We found that baricitinib substantially reduced T-cell cytokine production, decreasing IL-6, IL-17, IFN-γ, and IL-21 in CD4<sup>+</sup> T cells and IL-6 in CD8<sup>+</sup> T cells, accompanied by lower IFN-γ/IL-17 and IL-21/IL-6 ratios, respectively. µCT analyses showed no significant intergroup differences in BV/TV, whereas histomorphometry demonstrated higher BV/TV in the baricitinib group. Overall, baricitinib was found to effectively suppressed proinflammatory cytokines in aged SAMP8 mice but did not consistently enhance bone parameters, indicating reduced skeletal responsiveness during aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/ijms27115047
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
K, G., V, K., M, B., K, W., M, S., A, M., & P., P. (2026). Effect of the JAK Inhibitor Baricitinib on Cytokine Production and Bone Properties in a Mouse Model of Accelerated Aging. <em>International journal of molecular sciences</em>. https://doi.org/10.3390/ijms27115047
Vancouver
K G, V K, M B, K W, M S, A M, et al. Effect of the JAK Inhibitor Baricitinib on Cytokine Production and Bone Properties in a Mouse Model of Accelerated Aging. International journal of molecular sciences. 2026. doi:10.3390/ijms27115047.
BibTeX
@article{gelles2026Effect,
title = {Effect of the JAK Inhibitor Baricitinib on Cytokine Production and Bone Properties in a Mouse Model of Accelerated Aging.},
author = {Gelles K and Kurz V and Butylina M and Wahl-Figlash K and Schepelmann M and Meshcheryakova A and Pietschmann P.},
journal = {International journal of molecular sciences},
year = {2026},
doi = {10.3390/ijms27115047},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2018
Citation only
The Relationship of Peak Bone Mass, Aging, and Bone Loss to Osteoporosis and Fragility Fractures
Osteoporosis International 2009
Citation only
Bone ultrastructure: evolution during osteoporosis and aging
biorxiv 2024
Preprint · CC-BY
Chronic IL-6 overproduction induces a tolerogenic response in aged mice after peripheral nerve injury
Aging Cell 2025
Open access · CC-BY
Senescent Cells Involved in Deterioration of Bone Microstructure by High‐Frequency Parathyroid Hormone 1–34 Administration and Bone Loss
PubMed 1976
Preprint
Patterns of age-related cortical bone loss (osteoporosis) within the femoral diaphysis.
Endocrinology and Metabolism Clinics of North America 2005
Citation only